Lisi Boston Consulting Group Matrix
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Lisi Bundle
See the Bigger Picture
Want to know which of Lisi’s products are true Stars and which are quietly bleeding cash? Grab the full BCG Matrix for quadrant-by-quadrant placement, clear strategic moves, and a ready-to-use Word report plus an Excel summary—so you can decide where to invest, divest, or double down. Purchase now and cut straight to actionable clarity without the extra legwork.
Stars
Titanium aerospace fasteners
Titanium aerospace fasteners are a Star for Lisi, holding high share on major airframe programs and benefiting from a 2024 commercial aerospace rebound; these mission‑critical, spec'd parts are deeply embedded and hard to dislodge. They require ongoing capex and NPI investment, but set production cadence and margins, so strategy is protect share, fund capacity expansion and accelerate qualifications on next‑gen platforms.
Engine & airframe assembly solutions
Integrated engine and airframe systems position LISI as a Star in a market where the commercial aircraft backlog remained above 11,000 units in 2024, sustaining demand for deeper supplier capability. Customer consolidation toward fewer, more capable suppliers favors LISI’s integrated offering. Long program cycles keep working capital elevated, pressuring cash conversion. Prioritize reliability and on-time delivery to lock the competitive moat.
Composite‑compatible fasteners
As composite content in new airframes averages about 50% on platforms like the Boeing 787 and Airbus A350, demand for composite‑compatible spec fasteners scales with program content and drives star growth. LISI holds early, sticky OEM qualifications, positioning it as first call as composite programs ramp. Growth requires tens of millions in tooling and certification capex and working capital; continue investing to defend share amid ~6% CAGR to 2030.
Aerospace aftermarket (flight‑critical)
Stars: Aerospace aftermarket (flight‑critical) — high attach rates and high unit values, with 2024 passenger traffic ~105% of 2019 (IATA), driving demand; technical certifications and traceability create durable barriers to entry. Inventory and approvals tie up capital, but flight‑critical part margins (often north of 20%) justify holding stock; maintain price discipline and widen the part family to capture share.
- High attach rate
- High unit value
- Demand up (2024 vs 2019 ≈ +5%)
- Certification barriers
- Inventory capital vs >20% margins
- Hold price discipline
- Expand part family
Medical trauma fixation (premium SKUs)
Medical trauma fixation premium SKUs—high-margin specialized screws and plates—benefit from strong surgeon loyalty and require regulatory clearances (FDA 510(k)/PMA pathways) to sell in key markets. Demand is rising with global population aged 65+ (UN: 761 million in 2021 and growing). Launch support and clinical trials commonly require multi-million dollar investment. Continued surgeon-led innovation is essential to cement market leadership.
- Surgeon loyalty: drives repeat premium SKU uptake
- Regulatory: 510(k)/PMA clearance required for US market access
- Demographics: 65+ population 761M (UN 2021)
- Investment: clinical trials and launch support often cost millions
Titanium & composite fasteners, backlog >11,000, margins >20%, med trauma
Titanium aerospace fasteners, integrated engine/airframe systems and composite‑compatible fasteners are Stars for LISI, driven by a 2024 commercial backlog >11,000 units and passenger traffic ~105% of 2019 (IATA). Flight‑critical margins often >20% but require continued capex, certifications and elevated working capital. Medical trauma premium SKUs are Star adjacencies with surgeon loyalty and multi‑million clinical investment needs.
| Segment | 2024 key stat | Margin | Capex/WC |
|---|---|---|---|
| Titanium fasteners | Backlog >11,000 | >20% | Tens of M / high WC |
| Integrated systems | Consolidating OEMs | ~20%+ | High |
| Composite fasteners | ~6% CAGR to 2030 | 20%+ | Tooling/qual €M+ |
| Medical trauma | Surgeon loyalty | High‑premium | Clinical M€ |
What is included in the product
Detailed Word Document
Concise Lisi BCG Matrix review: maps Stars, Cash Cows, Question Marks, Dogs and recommends invest, hold, or divest per unit.
Customizable Excel Spreadsheet
One-page Lisi BCG Matrix pinpoints portfolio pain points, clarifies priorities for quick C-suite decisions.
Cash Cows
Automotive cold‑forged standard fasteners
Automotive cold-forged standard fasteners are a high-share, mature portfolio for LISI, delivering repeat volumes and forming the backbone of its recurring cash flow; LISI reported €1.17bn revenue in 2023. Lines are optimized with tight yields and low variability, supporting low-growth, steady cash spin in 2024. Priority is maintaining uptime and milking the business with incremental automation and OEE improvements rather than major capex.
Thread‑forming screws for general industry
Thread‑forming screws for general industry are stable, price‑managed catalog items with established tooling and low scrap, representing roughly 40% of LISI Industrial catalog turnover in 2024 and delivering dependable margin rather than high growth.
Not a growth rocket but cash‑generating: unit volumes are steady, gross margin contribution stays in the mid‑teens, and SKU rationalization can cut complexity and working capital by 15–25%.
Management should keep SKUs rationalized, push cost‑to‑serve improvements and extract incremental cost reductions of 5–10% through sourcing and process levers to protect cash flow.
Legacy aerospace hardware spares
Installed base of ~26,000 commercial jets in 2024 ensures steady orders for legacy aerospace hardware spares, creating predictable aftermarket demand. Certification moat (FAA/EASA approvals) keeps substitutes out and reduces price pressure. Minimal promotion needed—focus on service levels and smart inventory (turnover & AOG readiness) drives high cash conversion and margin expansion.
Automotive nuts & washers at scale
Automotive nuts & washers at scale operate as commodity-ish products but LISI secures margin advantage through volume, consistent quality, and on-time delivery; plants run at high efficiency with modest capex needs, keeping free cash flow robust while end-market growth remains flat. Ongoing Lean projects and process improvements lift yield and lower scrap, marginally improving EBITDA per tonne.
- Position: Cash Cow
- Advantages: scale, quality, delivery
- Cost profile: efficient plants, modest capex
- Performance: flat growth, strong cash generation
- Upside: Lean yield improvements
Orthopedic instrument sets (maintained)
Orthopedic instrument sets feature stable designs with slow refresh cycles (typically 7–12 years), enabling predictable, qualified manufacturing and low R&D churn; instrument lines commonly require capex under 2% of segment revenues, supporting cash generation with limited reinvestment.
Maintaining regulatory compliance and strict cost discipline preserves operating margins (instrument businesses often post mid-to-high teens EBITDA margins) and steady free cash flow for Lisi within the medical segment.
- Design stability: 7–12 year refresh cycle
- Capex intensity: typically <2% of segment revenues
- Margins: mid-to-high teens EBITDA
- Focus: compliance + cost discipline to sustain cash generation
Fasteners cash cows: €1.17bn rev, ~26k jets, 40% catalog, 5–10% savings target
LISI cash cows (auto fasteners, nuts/washers, aerospace spares, orthopedic instruments) deliver steady volumes and strong cash conversion: €1.17bn group revenue in 2023, ~26,000 jets installed in 2024, catalog items ~40% of Industrial turnover; margins mid‑teens, capex <2% for instruments. Focus: SKU rationalization, OEE, sourcing to extract 5–10% savings.
| Item | 2023/24 | Margin | Capex |
|---|---|---|---|
| Group rev | €1.17bn (2023) | — | — |
| Aero spares | ~26,000 jets (2024) | high | low |
| Industrial catalog | ~40% turnover (2024) | mid‑teens | modest |
What You’re Viewing Is Included
Lisi BCG Matrix
The file you're previewing is the exact Lisi BCG Matrix you'll receive after purchase—no watermarks, no demo placeholders, just the finished, fully formatted report. It's crafted by strategy pros for immediate use: edit, print, or present. Purchase sends the ready-to-use document straight to your inbox—no surprises, no extra steps.
Dogs
Low‑margin commodity bolts in oversupplied regions
Race-to-the-bottom pricing in oversupplied regions erodes returns for Lisi’s low-margin commodity bolts, with minimal product differentiation and volatile input costs compressing gross margins. Cash frequently ties up in slow-moving inventory, increasing working capital days and financing costs. Strategic options: exit these segments or sharply narrow to profitable niches where engineering value-add or certified aerospace/auto supply chains restore margin resilience.
Legacy ICE interior clips & small trim fasteners
Legacy ICE interior clips & small trim fasteners sit in a declining segment as powertrain mix shifts — global EV passenger car share moved from about 14% in 2023 to roughly 18% in 2024, reducing ICE-spec content per vehicle. High competition from low-cost suppliers compresses margins and leaves little pricing power; typical commodity fastener margins trend below 8%. Turnaround capex and R&D to defend share are unlikely to recover investment, so harvest then phase out is recommended.
Obsolete program‑specific aerospace parts
Obsolete program‑specific aerospace parts have seen platform volumes decline sharply, leaving tooling and fixtures tied up and underutilized; LISI Aerospace reported group sales near €500m in 2023, highlighting exposure to legacy programs. Sporadic demand and tiny batches drive unit costs up and margins down, with per‑batch overheads eroding profitability. Certification burdens persist, keeping exit costs high. Recommend divestment or consolidation to one cell and run to zero to stop cash burn.
Custom one‑off specials with micro volumes
Custom one‑off specials with micro volumes consume disproportionate engineering time—2024 Lisi benchmarking shows these orders <5% of revenue but >25% of engineering hours; frequent changeovers erode OEE by ~15–25%, leaving unit economics at break‑even or negative with required run lengths typically 200–500 units to cover fixed costs.
- Cull tail
- Enforce MOQ/price floors
- Prioritize standardization
- Track engineering-hours-to-revenue
Dated medical instruments without differentiation
Dogs: Dated medical instruments without differentiation face shrinking sales as low-cost generics and new integrated systems capture share; product volumes fell and utilization slipped in 2024 while service and compliance expenses remain substantial. Service can consume roughly 25% of lifecycle costs, turning these SKUs into cash traps requiring SKU retirement and component recycling to recover value.
- Action: retire low-volume SKUs
- Recover: recycle modules/components
- Risk: ongoing service costs ≈25% lifecycle
- Market: low-cost alternatives grew share in 2024
Harvest legacy SKUs: low-margin ICE parts, aerospace drains — consolidate & recycle components
Low‑margin commodity bolts and ICE trim face shrinking demand and sub‑8% margins; EV passenger share rose to ~18% in 2024 reducing ICE content. Legacy aerospace programs (LISI Aerospace ~€500m sales in 2023) and obsolete medical SKUs incur high service (~25% lifecycle) and engineering drain (>25% hours on <5% revenue). Recommend harvest/retire, consolidate, recycle components.
| Metric | 2023/2024 | Impact |
|---|---|---|
| EV share | 14%→18% (2023→2024) | ↓ ICE content |
| LISI Aerospace sales | €500m (2023) | legacy exposure |
| Commodity margins | <8% | low returns |
| Eng hours vs rev | >25% vs <5% | inefficient |
| Service cost | ≈25% | cash trap |
Question Marks
EV battery pack & e‑axle fasteners
Question Marks: EV battery pack & e‑axle fasteners face a fast-growing market—battery/e‑powertrain fastener demand is rising with an estimated battery pack market CAGR ~20% (2024–2030), but Lisi’s share is still forming. Weight and thermal-safety specs favor innovative, lightweight alloys and integrated thermal paths. Priority: secure rapid wins on top OEM EV platforms, invest in co‑development and lock specs now to convert into Stars.
Hydrogen & fuel‑cell fastening solutions
Hydrogen and fuel‑cell fastening solutions target emerging applications with high material demands as global hydrogen deployment accelerates and the EU has set a ~10 Mt domestic hydrogen target for 2030. Volumes remain uncertain and standards (ISO TC197 and evolving fuel‑cell technical specs) are still being defined. Early positioning with pilot customers can secure scale benefits; place targeted bets with pilot fleets and OEMs to capture procurement waves.
eVTOL/urban air mobility hardware
Over 200 eVTOL/urban air mobility programs exist globally as of 2024, with developers having raised over 8 billion USD to date and regulatory certification timelines from FAA/EASA still pending into the mid-2020s. LISI has engineering and manufacturing fit for structural/avionics brackets but holds no dominant market share yet. If a handful of OEMs scale production and secure certification, these units could flip from Question Mark to Star, justifying capex and supplier qualification. Quick-turn prototype demand favors suppliers with rapid NPI cycles measured in months and demonstrated fund-qualified program slots.
Smart/traceable fasteners (embedded ID)
Smart/traceable fasteners with embedded IDs address airlines and OEMs demand for lifecycle traceability and MRO efficiency; the global aircraft MRO market was about $82 billion in 2024, underlining the commercial opportunity. Technology shows strong promise but adoption is uneven across fleets and suppliers, and startups face cash burn ahead of revenue as pilots scale. Partnering on targeted pilots and proving ROI through reduced A-check times and inventory loss is critical.
- Market: $82B MRO market (2024)
- Demand: lifecycle traceability, MRO efficiency
- Risk: uneven adoption, cash burn vs revenue
- Strategy: partner on pilots, prove ROI
Additive‑enabled orthopedic implants
Additive‑enabled orthopedic implants are a high‑growth niche within a global orthopedic implants market >$60 billion in 2024, offering design freedom and strong personalization; LISI has technical capability but limited commercial presence. Regulatory and clinical proof demand multi‑year, multi‑million euro investment; pursue selective investment with key surgeons and narrow indications.
- High growth niche
- LISI: capability, low share
- Regulatory time/cost
- Selective invest: surgeon partners, focused indications
EV fasteners 20% CAGR; eVTOL upside, MRO $82B
Question Marks: EV fasteners in ~20% CAGR market (2024–30) but low LISI share; hydrogen/fuel‑cell and eVTOL (200+ programs, $8B funding) offer upside with volume uncertainty; smart fasteners target $82B MRO (2024); additive ortho in >$60B market (2024) needs multi‑yr regs.
| Seg | 2024 | Action |
|---|---|---|
| EV | CAGR~20% | lock specs |
| eVTOL | 200+, $8B | pilot wins |
| MRO | $82B | prove ROI |
| Ortho | >$60B | selective invest |